143 related articles for article (PubMed ID: 12735281)
1. [Computerized monitoring for integrated cervical screening. Rationale, methods and indicators of participation].
Bucchi L; Pierri C; Caprara L; Cortecchia S; De Lillo M; Bondi A
Pathologica; 2003 Feb; 95(1):9-21. PubMed ID: 12735281
[TBL] [Abstract][Full Text] [Related]
2. Augmentation of Pap smear screening of high risk aboriginal women. Use of a computerised process tool within the Broome Aboriginal Medical Service.
Couzos S; Wronski I; Murray R; Cox H
Aust Fam Physician; 1998 Apr; 27(4):269-74. PubMed ID: 9581335
[TBL] [Abstract][Full Text] [Related]
3. [Computerised monitoring of integrated cervical screening. Indicators of diagnostic performance].
Bucchi L; Pierri C; Amadori A; Folicaldi S; Ghidoni D; Nannini R; Bondi A
Pathologica; 2003 Dec; 95(6):436-43. PubMed ID: 15080522
[TBL] [Abstract][Full Text] [Related]
4. [Cervical cancer screening for high risk women: is it possible? Results of a cervical cancer screening program in three suburban districts of Lyon].
Mignotte H; Perol D; Fontanière B; Nachury LP; Blanc-Jouvand A; Fouillat V; Chauvin F; Lasset C
Bull Cancer; 1999 Jun; 86(6):573-9. PubMed ID: 10417430
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of cervical cancer screening program at a rural community of South Africa.
Hoque M; Hoque E; Kader SB
East Afr J Public Health; 2008 Aug; 5(2):111-6. PubMed ID: 19024420
[TBL] [Abstract][Full Text] [Related]
6. Screening-preventable cervical cancer risks: evidence from a nationwide audit in Sweden.
Andrae B; Kemetli L; Sparén P; Silfverdal L; Strander B; Ryd W; Dillner J; Törnberg S
J Natl Cancer Inst; 2008 May; 100(9):622-9. PubMed ID: 18445828
[TBL] [Abstract][Full Text] [Related]
7. Effect of an antepartum Pap smear on the coverage of a cervical cancer screening programme: a population-based prospective study.
Nygård M; Daltveit AK; Thoresen SO; Nygård JF
BMC Health Serv Res; 2007 Jan; 7():10. PubMed ID: 17244348
[TBL] [Abstract][Full Text] [Related]
8. Report from the CDC. Pap test intervals used by physicians serving low-income women through the National Breast and Cervical Cancer Early Detection Program.
Cooper CP; Saraiya M; McLean TA; Hannan J; Liesmann JM; Rose SW; Lawson HW
J Womens Health (Larchmt); 2005 Oct; 14(8):670-8. PubMed ID: 16232098
[TBL] [Abstract][Full Text] [Related]
9. Validity of self-reported Pap smear history in Norwegian women.
Klungsøyr O; Nygård M; Skare G; Eriksen T; Nygård JF
J Med Screen; 2009; 16(2):91-7. PubMed ID: 19564522
[TBL] [Abstract][Full Text] [Related]
10. [Screening for cervical cancer in the county of Funen. Status of 25 years of development and experiences].
Hølund B; Grinsted P
Ugeskr Laeger; 2006 May; 168(22):2163-6. PubMed ID: 16768956
[TBL] [Abstract][Full Text] [Related]
11. Trends in abnormal cancer screening results in the United States of America.
Yabroff KR; Freedman A; Brown ML; Ballard-Barbash R; McNeel T; Taplin S
J Med Screen; 2007; 14(2):67-72. PubMed ID: 17626704
[TBL] [Abstract][Full Text] [Related]
12. Cervical cancer screening among U.S. women: analyses of the 2000 National Health Interview Survey.
Hewitt M; Devesa SS; Breen N
Prev Med; 2004 Aug; 39(2):270-8. PubMed ID: 15226035
[TBL] [Abstract][Full Text] [Related]
13. Women's compliance with public health guidelines for mammograms and pap tests in Canada and the United States: an analysis of data from the Joint Canada/United States Survey Of Health.
Blackwell DL; Martinez ME; Gentleman JF
Womens Health Issues; 2008; 18(2):85-99. PubMed ID: 18182305
[TBL] [Abstract][Full Text] [Related]
14. Organization and results of cervical cancer screening in the German Democratic Republic.
Ebeling K; Nischan P
IARC Sci Publ; 1986; (76):251-66. PubMed ID: 3570410
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of visual inspection with acetic acid (VIA), Lugol's iodine (VILI), cervical cytology and HPV testing as cervical screening tools in Latin America. This report refers to partial results from the LAMS (Latin AMerican Screening) study.
Sarian LO; Derchain SF; Naud P; Roteli-Martins C; Longatto-Filho A; Tatti S; Branca M; Erzen M; Serpa-Hammes L; Matos J; Gontijo R; Bragança JF; Lima TP; Maeda MY; Lörincz A; Dores GB; Costa S; Syrjänen S; Syrjänen K
J Med Screen; 2005; 12(3):142-9. PubMed ID: 16156945
[TBL] [Abstract][Full Text] [Related]
16. Challenges in starting organised screening programmes for cervical cancer in the new member states of the European Union.
Nicula FA; Anttila A; Neamtiu L; Zakelj MP; Tachezy R; Chil A; Grce M; Kesić V
Eur J Cancer; 2009 Oct; 45(15):2679-84. PubMed ID: 19699083
[TBL] [Abstract][Full Text] [Related]
17. [The 1996 revision of the Dutch cervical cancer screening programme: increased coverage, fewer repeat smears and less opportunistic screening].
Berkers LM; van Ballegooijen M; van Kemenade FJ; Rebolj M; Essink-Bot ML; Helmerhorst TJ; Habbema JD
Ned Tijdschr Geneeskd; 2007 Jun; 151(23):1288-94. PubMed ID: 17624160
[TBL] [Abstract][Full Text] [Related]
18. Cervical cancer in women with comprehensive health care access: attributable factors in the screening process.
Leyden WA; Manos MM; Geiger AM; Weinmann S; Mouchawar J; Bischoff K; Yood MU; Gilbert J; Taplin SH
J Natl Cancer Inst; 2005 May; 97(9):675-83. PubMed ID: 15870438
[TBL] [Abstract][Full Text] [Related]
19. Decisions about Pap tests: what influences women and providers?
Fiebig DG; Haas M; Hossain I; Street DJ; Viney R
Soc Sci Med; 2009 May; 68(10):1766-74. PubMed ID: 19339094
[TBL] [Abstract][Full Text] [Related]
20. [Evaluation of a cervical cancer screening campaign: reflections on the experience in Martinique].
Briollais L; Feyler A; Ossondo M; Dorival MJ; Le Mab G; Escarmant P; Azaloux H
Sante Publique; 2000 May; 12 Spec No():21-35. PubMed ID: 10989626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
